Emcure Pharmaceuticals fundamental analysis

EMCURE

1485.3

49.80 (3.47%)
Last updated on 1 Feb, 2026 | 15:51 IST
alert_iconwatchlist_icon
BUYSELL

alert_iconThe current prices are delayed, login to your account for live prices

Emcure Pharmaceuticals Fundamentals

P/E Ratio

35.01

P/B Ratio

5.85

Div. Yield

0.2

Sector P/E

65.25

Sector P/B

1.2

Sec. Div. Yield

0.58

Emcure Pharmaceuticals Fundamentals is currently trading with a P/E Ratio of 35.01, compared to the sector average of 65.25. Its P/B Ratio stands at 5.85, while the sector’s is 1.2. In terms of returns, the stock offers a Dividend Yield of 0.2%, which is than the sector’s 0.58%.

Emcure Pharmaceuticals Score Card

  • price_icon
    Price

    Expensive

  • chart_icon
    Growth

    Average

  • quality_check
    Quality

    Good

  • quality_check
    Management

    Good

On its scorecard, Emcure Pharmaceuticals reflects: Price – Expensive, Growth – Average, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.